NCT06360705 - StrataMGT for the Treatment of Vulvar Lichen Sclerosus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

November 30, 2024

Conditions

Vulvar Lichen Sclerosus

Interventions

DEVICE

StrataMGT

StrataMGT® is a semi-permeable, non-resorbable and self-drying gel. StrataMGT® contains no steroids, hormones, alcohol, parabens or fragrances. StrataMGT® gel is bacteriostatic, inert, and is manufactured in compliance with good manufacturing practices (GMPs), 21CFR210 and 211.

Trial Locations (1)

10036

Centers for Vulvovaginal Disorders, New York

All Listed Sponsors

collaborator

Stratpharma AG

INDUSTRY

lead

Center for Vulvovaginal Disorders

OTHER